Persistence of human papillomavirus infection: keys to malignant progression

被引:234
作者
Bodily, Jason [1 ]
Laimins, Laimonis A. [1 ]
机构
[1] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
TYPE-16; E7; ONCOPROTEIN; LIFE-CYCLE; IN-VITRO; IMMUNE-RESPONSES; PRODUCTIVE CYCLE; NATURAL-HISTORY; MOUSE MODEL; PROTEIN; DIFFERENTIATION; EXPRESSION;
D O I
10.1016/j.tim.2010.10.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human papillomaviruses (HPVs) are the etiologic agents of cervical and other epithelial cancers. Persistence of infections by high-risk HPV types is the single greatest risk factor for malignant progression. Although prophylactic vaccines have been developed that target high-risk HPV types, there is a continuing need to understand better the virus-host interactions that underlie persistent benign infection and progression to cancer. In this review we summarize the molecular events that facilitate the differentiation-dependent HPV life cycle, how the life cycle is organized to facilitate virus persistence, and how the activities of HPV regulatory proteins result in malignancy.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 74 条
[1]  
Akers Aletha Y, 2007, Curr Probl Cancer, V31, P157, DOI 10.1016/j.currproblcancer.2007.01.001
[2]   In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells [J].
Alcocer-Gonzalez, Juan Manuel ;
Berumen, Jaime ;
Tamez-Guerra, Reyes ;
Bermudez-Morales, Victor ;
Peralta-Zaragoza, Oscar ;
Hernandez-Pando, Rogelio ;
Moreno, Jose ;
Gariglio, Patricio ;
Madrid-Marina, Vicente .
VIRAL IMMUNOLOGY, 2006, 19 (03) :481-491
[3]   Status of local cellular immunity in interferon-responsive and -nonresponsive human papillomavirus-associated lesions [J].
Arany, I ;
Tyring, SK .
SEXUALLY TRANSMITTED DISEASES, 1996, 23 (06) :475-480
[4]   Negative and positive regulation of HIF-1:: A complex network [J].
Bárdos, JI ;
Ashcroft, M .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2005, 1755 (02) :107-120
[5]   AMPLIFICATION OF HUMAN PAPILLOMAVIRUS GENOMES INVITRO IS DEPENDENT ON EPITHELIAL DIFFERENTIATION [J].
BEDELL, MA ;
HUDSON, JB ;
GOLUB, TR ;
TURYK, ME ;
HOSKEN, M ;
WILBANKS, GD ;
LAIMINS, LA .
JOURNAL OF VIROLOGY, 1991, 65 (05) :2254-2260
[6]   Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31 [J].
Chang, YJE ;
Laimins, LA .
JOURNAL OF VIROLOGY, 2000, 74 (09) :4174-4182
[7]   Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior [J].
Chen, W. ;
Li, F. ;
Mead, L. ;
White, H. ;
Walker, J. ;
Ingram, D. A. ;
Roman, A. .
VIROLOGY, 2007, 367 (01) :168-174
[8]   Requirement for Estrogen Receptor α in a Mouse Model for Human Papillomavirus-Associated Cervical Cancer [J].
Chung, Sang-Hyuk ;
Wiedmeyer, Kerri ;
Shai, Anny ;
Korach, Kenneth S. ;
Lambert, Paul F. .
CANCER RESEARCH, 2008, 68 (23) :9928-9934
[9]   The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism [J].
Clere, Nicolas ;
Bermont, Laurent ;
Fauconnet, Sylvie ;
Lascombe, Isabelle ;
Saunier, Maelle ;
Vettoretti, Lucie ;
Plissonnier, Marie-Laure ;
Mougin, Christiane .
EXPERIMENTAL CELL RESEARCH, 2007, 313 (15) :3239-3250
[10]   p63 in Epithelial Survival, Germ Cell Surveillance, and Neoplasia [J].
Crum, Christopher P. ;
McKeon, Frank. D. .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2010, 5 :349-371